SMN2 and proximal spinal muscular atrophy: Here, we demonstrated an inflammatory peripheral signature, that changes upon the SMN2 modulating treatment, and the presence of inflammatory mediators in CSF of SMA patients, thus supporting an inflammatory/immunological contribution to SMA.